Search results
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 week agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
Opinion | Now is the time to talk about vaccines, but Covid-19 leaves polarising legacy
South China Morning Post· 8 hours agoOther drug makers such as BioNTech and Serum Institute have also faced lawsuits in Germany and India...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
What's Going With BioNTech Stock On Monday?
Benzinga· 1 week agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 2 weeks agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 2 weeks agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 1 week agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 1 week agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 2 weeks agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and ...
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week agoThe [Inaudible] category are mRNA vaccines, which are the centerpiece of our oncology strategy. Our mRNA cancer vaccines are designed to target multiple...